Abstract
In this study, heparin-loaded poly-ɛ-caprolactone (PCL) fibrous mats were prepared and characterized based on their physical, cytotoxic, thermal, and biological properties. The main objective of the work described here was to test the hypothesis that incorporation of heparin into a PCL carrier could serve as bio-compatible material capable of inhibiting Human Papillomavirus (HPV) infection. The idea of firmly anchoring heparin to capture soluble virus, vs. a slow heparin release to inhibit a virus in solution was tested. Thus, one material was produced via conventional heparin matrix encapsulation and electrohydrodynamic fiber processing in one step. A second type of material was obtained via heparin crosslinking. This was achieved by running a carbodiimide/N-hydroxysuccinimide (EDC/NHS) coupling reaction on preformed PCL fibers. In vitro HPV16 L1 protein binding capacity studies were performed. Infectivity assays were done using HPV16 pseudoviruses (PsVs) carrying a GFP plasmid to directly test the ability of the fibrous mats to prevent internalization of HPV PsVs. The crosslinked heparin material presented a dissociation constant (Kd) value comparable to those found in the literature for different heparin-protein L1 peptide interactions. Both materials significantly reduced internalization of HPV PsVs, with a reduction of 94% of PsVs internalization when matrix encapsulated heparin-loaded material was present. Differences in performance between the two proposed structures are discussed.
Highlights
Human Papillomavirus (HPV), the most common worldwide sexually transmitted virus, infects the squamous mucosal layers of the stratified epithelium
Two different approaches to produce heparin-loaded poly-ε-caprolactone (PCL) fibrous materials were applied in this study
Both materials showed good cell viability properties, and the incorporation of heparin into the fibers improved the hydrophilicity of the materials, and decreased polymer crystallinity
Summary
Human Papillomavirus (HPV), the most common worldwide sexually transmitted virus, infects the squamous mucosal layers of the stratified epithelium. Of the more than 200 HPV genotypes known, about 16 are associated with cancers of the penis, vulva, anus, vagina, cervix, and oropharynx [1,2,3]. About 14 million new HPV infections occur annually in the United States (US) [4]. Most HPV infections are asymptomatic and typically clear without any treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.